NIH U19 funding opportunities: Research Program Cooperative Agreement
4 NIH notices for U19 (Research Program Cooperative Agreement) are open and 3 forecast. Several related projects under one award, with substantial NIH...
- Open notices4
- Forecast3
- Projects funded under them1,714
Open NIH U19 notices
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Open - Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
Open - National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
Open - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Open
Forecast U19 notices
- Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
Forecast - Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)
Forecast - Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)
Forecast
Institutes that fund U19 projects under these notices
| Institute or center | Projects |
|---|---|
| National Cancer Institute (NCI) | 232 |
| National Institute of General Medical Sciences (NIGMS) | 210 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 169 |
| National Institute on Aging (NIA) | 152 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 151 |
| National Heart Lung and Blood Institute (NHLBI) | 134 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 96 |
| National Institute on Drug Abuse (NIDA) | 80 |
| National Institute of Mental Health (NIMH) | 66 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 65 |
Closed U19 notices
- RFA-NS-27-011: Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed)
- RFA-AI-27-004: Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
- RFA-RM-24-008: Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
- RFA-AI-25-012: Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
- PAR-22-213: Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
- RFA-AI-24-079: Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
- PAR-23-033: Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)
- PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
- PAR-22-144: National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional)
- RFA-HD-25-003: Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)
- RFA-NS-22-040: BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)
- RFA-AI-24-020: Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
- RFA-MD-24-009: Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)
- RFA-HD-25-004: Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional)
- RFA-NS-22-039: BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Basic Experimental Studies with Humans Required)
- RFA-AI-23-065: Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
- RFA-AI-23-057: Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed)
- RFA-AG-24-017: Limited Competition: Renewal of the Longevity Consortium (U19 Clinical Trial Not Allowed)
- RFA-NS-22-052: HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
- RFA-NS-24-011: Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)
- RFA-CA-23-026: Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
- RFA-AI-23-019: Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)
- RFA-AI-23-020: Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed)
- RFA-AI-23-015: Genomics Centers for Infectious Diseases (U19 Clinical Trial Not Allowed)
- RFA-NS-24-001: Using Multimodal Biomarkers to Differentially Diagnose ADRDs for Clinical Trials (U19 Clinical Trial Optional)
- RFA-AI-22-070: Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed)
- RFA-AI-22-067: International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)
- RFA-AI-22-069: Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)
- RFA-NS-22-018: HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed)
- RFA-RM-22-015: IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed)
- RFA-AI-21-079: Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
- RFA-AI-22-001: Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed)
- RFA-AI-22-003: Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U19 Clinical Trial Not Allowed)
- RFA-NS-21-015: HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
- PAR-21-156: The Midlife in the United States Study (U19 Clinical Trial Not Allowed)
- RFA-AI-21-065: Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed)
- RFA-AI-21-050: Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed)
- RFA-AI-20-078: Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
- RFA-AI-20-079: Human Immunology Project Consortium (U19 Clinical Trial Optional)
Questions people ask
What is an NIH U19?
U19 is NIH's activity code for the Research Program Cooperative Agreement. Several related projects under one award, with substantial NIH involvement. Each notice sets its own budget limit, project length and due dates.
How many NIH U19 funding opportunities are open?
4 notices are open on Grants.gov, and 3 more are forecast, as of the latest data.